Purchase Order 75N93025P01117

Award Date 9/30/25
Potential Completion Date 9/29/26
Potential Value $63K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Carlsbad, CA 92008, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract was awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. The $33,800 firm-fixed-price purchase order is for the supply of cell growth culture media such as EXPI293, DMEM, trypsin, PBS, and RPMI. These specialized consumable supplies are required by NIAID's Vaccine Research Center, Immunology Laboratory, and Biodefense Research Section...
This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific. The $24,961.30 contract is for the purchase of EXPI293 expression mediums and FREESTYLE293 expression mediums, which are likely reagents or consumables used in biomedical research and medical countermeasure development. The award...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific. The contract, valued at $29,640.00, is for the provision of Freestyle 293 expression medium, a specialized cell culture product used in biomedical research. The contract does not have a set-aside designation. Life Technologies has...
The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $43,616 firm fixed price purchase order to Life Technologies Corporation. Under this contract, Life Technologies will provide 32 units of EXPI 293 Expression Media to the agency in five shipments for use in its research programs. Performance will occur in Carlsbad, California and last through the end of calendar year 2024. No set aside designation or...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific. The $99,558.72 contract is for the supply of "Expression Media and Medium" products and related services, with a period of performance through August 12, 2025. Life Technologies Corporation is a leading provider of...
This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The $19,380.00 firm fixed price purchase order is for EXPI293 Expression Medium and ExpiFectamine 293 Transfection Kit products, which support biomedical research. Life Technologies is a division of the parent company...
Life Technologies Corporation, a subsidiary of Thermo Electron Corporation Financial Services Division, has been awarded a $45,220 firm fixed price purchase order by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health within the Department of Health and Human Services. The contract calls for the delivery of FREESTYLE 293 EXPRESSION MEDIA, EXPI293 EXPRESSION MEDIUM 6 X 1L AND HT SUPPLEMENT to the prime contractor's facility in Grand...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. government, to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. The contract is for the procurement of ExpiFectamine transfection kits and OptiMEM media, which are used in the production of recombinant proteins and monoclonal antibodies for NIAID's Vaccine Research Center. The total ceiling value of the contract is...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order contract to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The contract, valued at $113,690.02, is for the provision of biologicals and mediums, with a completion date of March 7, 2022. Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, has a history of...
This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. Department of Health and Human Services, to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The contract, valued at $51,260.80, is for the procurement of 8 units of the ExpiFectamine 293 Transfection Kit, a 10-liter product, to be used by NIAID's Vaccine Research Center in its efforts to develop...

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $63,396.00 firm fixed-price purchase order to Life Technologies Corporation, doing business as Thermo Fisher Scientific, for the procurement of Freestyle 293 Expression Medium and EXPI293 Expression Medium. These specialized cell culture media products are critical for protein and antibody production in vaccine development research targeting HIV-1, SARS-CoV-2, and other viruses at the NIAID Vaccine Research Center. The award was made through full and open competition, with a brand name restriction limiting the procurement to Life Technologies products. The performance period is from August 1, 2023, to July 31, 2024, with delivery required within 30 days to the NIAID facility in Bethesda, Maryland. This purchase order is not associated with a larger contract vehicle and does not have a set-aside designation.

Generated 9/30/25, 9:42 AM